Wall St. ends lower with oil prices, renewed Greece worries
DJ: 17,673.02 +6.62 NAS: 4,716.70
-11.04 S&P: 2,041.51
-8.52
NEW
YORK Wed Feb 4, 2015 5:09pm EST
(Reuters) - The S&P 500 and Nasdaq ended lower on Wednesday, snapping a
two-day rally as energy shares slid with oil prices and as investors' anxiety
about the euro zone returned
in the closing minutes of trading.
The
benchmark index added to losses late in the session after the European Central Bank abruptly
cancelled its acceptance of Greek bonds in return for funding. The move
means the Greek central bank will have to provide its banks with tens of
billions of euros of additional emergency liquidity in coming weeks.
"It's
kind of reconfirming what we've thought for a while, which is that there is
going to be a liquidity crunch if they don't resolve this Greek
situation," said Larry Peruzzi, senior equity trader at Cabrera Capital
Markets Inc in Boston. "They make a little bit of progress and then they
kind of fall back."
Shares
of the Global X FTSE Greece 20 exchange-traded fund (GREK.P)
dropped 10.4 percent, with volume spiking late in the session. The euro EUR= also fell on the news, while the S&P financial
index .SPSY turned lower and ended down 0.3 percent.
The
Dow ended in positive territory, lifted by shares of Walt Disney (DIS.N),
up 8 percent to $101.64 after quarterly profit topped analysts' expectations.
The S&P 500 energy
index .SPNY was off 1.6 percent as oil prices declined after a four-day surge
of nearly 20 percent. U.S. crude CLc1 sank 8.7 percent to settle at
$48.45 following a new build in U.S. crude stockpiles.
The Dow Jones industrial average .DJI rose 6.62 points, or 0.04 percent, to
17,673.02, theS&P 500 .SPX lost 8.52 points, or 0.42 percent, to
2,041.51 and the Nasdaq Composite.IXIC dropped 11.04 points, or 0.23 percent,
to 4,716.70.
The
day's dip followed a two-day gain of 2.8 percent for the S&P 500, driven largely by the rebound in
energy shares.
Big biotechnology names
declined. Leading them lower was Gilead
Sciences (GILD.O),
whose stock dropped 8.2 percent to $98.43, a day after the drugmaker said it is
offering steeper-than-expected discounts on its hepatitis C drugs.
The
news fueled concerns the sector would face increasing price pressure. The Nasdaq Biotech Index .NBI was down 1.8 percent.
Gilead was also the biggest drag on the S&P
500and Nasdaq.
About
7.8 billion shares changed
hands on U.S. exchanges, below the 8.1 billion average for the last five
sessions, according to BATS Global Markets.
Declining
issues outnumbered advancing ones on the NYSE by 1,993 to 1,079, for a
1.85-to-1 ratio; on the Nasdaq, 1,677 issues
fell and 1,054 advanced for a 1.59-to-1 ratio. The S&P 500 was
posting 37 new 52-week highs and 3 lows; the Nasdaq Composite was recording 79 new highs and 34 lows.
No comments:
Post a Comment